{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:23:46Z","timestamp":1790673826736,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004800.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T00:00:00Z","timestamp":1417046400000}}],"reference-count":57,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004800.pub3","type":"journal-article","created":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T01:04:54Z","timestamp":1417050294000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Sulfasalazine for ankylosing spondylitis"],"prefix":"10.1002","volume":"2014","author":[{"given":"Junmin","family":"Chen","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Fujian Medical University; Department of Hematology and Rheumatology; #20 Chazhong Road Fuzhou Fujian Province China 350005"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaopeng","family":"Lin","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Fujian Medical University; Department of Hematology and Rheumatology; #20 Chazhong Road Fuzhou Fujian Province China 350005"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Hospital of Hebei Medical University; Division of Cardiology; 89 Donggang Road Shijiazhuang Hebei Province China 050031"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,11,27]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD004800.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO;2-C","article-title":"Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondyloarthropathies: a Department of Veterans Affairs cooperative study","volume":"42","author":"Clegg","year":"1999","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD004800.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/art.1780391209","article-title":"Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis: a Department of Veterans Affairs Cooperative Group","volume":"39","author":"Clegg","year":"1996","journal-title":"Arthritis and Rheumatism"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD004800.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"90s","DOI":"10.1016\/0197-2456(95)90513-5","article-title":"Longitudinal analysis of binary data in the V.A. Cooperative Study of sulfasalazine for the treatment of seronegative spondyloarthropathies","volume":"16","author":"Reda","year":"1995","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD004800.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/rheumatology\/29.1.41","article-title":"A controlled trial of sulphasalazine treatment of chronic ankylosing spondylitis: failure to demonstrate a clinical effect","volume":"29","author":"Corkill","year":"1990","journal-title":"British Journal of Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD004800.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/rheumatology\/28.5.410","article-title":"Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin","volume":"28","author":"Davis","year":"1989","journal-title":"British Journal of Rheumatology"},{"issue":"6552","key":"10.1002\/14651858.CD004800.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/bmj.293.6552.911","article-title":"Sulphasalazine in ankylosing spondylitis: A double blind controlled study in 60 patients","volume":"293","author":"Dougados","year":"1986","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD004800.pub3-BIB0007|cit7","first-page":"255","article-title":"Treatment of ankylosing spondylarthritis with salazosulfapyridin. A double-blind, controlled study in 60 patients","volume":"54","author":"Dougados","year":"1987","journal-title":"Revue du Rhumatisme et des Maladies Osteo Articulaires"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004800.pub3-BIB0008|cit8","first-page":"80","article-title":"Sulfasalazine in Spondylarthropathies","volume":"49","author":"Dougados","year":"1990","journal-title":"Zeitschrift fur Rheumatologie"},{"issue":"5","key":"10.1002\/14651858.CD004800.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/ard.45.5.396","article-title":"Sulphasalazine in ankylosing spondylitis","volume":"45","author":"Feltelius","year":"1986","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"8","key":"10.1002\/14651858.CD004800.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/rheumatology\/32.8.729","article-title":"The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years","volume":"32","author":"Kirwan","year":"1993","journal-title":"British Journal of Rheumatology"},{"issue":"5-6","key":"10.1002\/14651858.CD004800.pub3-BIB0011|cit11","first-page":"171","article-title":"Sulphasalazine in the treatment of ankylosing spondylitis","volume":"112","author":"Krajnc","year":"1990","journal-title":"Lijecnicki Vjesnik"},{"issue":"11","key":"10.1002\/14651858.CD004800.pub3-BIB0012|cit12","first-page":"2082","article-title":"Antibodies to Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in ankylosing spondylitis: effect of sulfasalazine treatment","volume":"21","author":"Nissila","year":"1994","journal-title":"Journal of Rheumatology"},{"issue":"9","key":"10.1002\/14651858.CD004800.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/art.1780310905","article-title":"Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial","volume":"31","author":"Nissila","year":"1988","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"10.1002\/14651858.CD004800.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s003930200024","article-title":"Sulfasalazine in ankylosing spondylitis: a prospective, randomized, double-blind placebo-controlled study and comparison with other controlled studies","volume":"61","author":"Schmidt","year":"2002","journal-title":"Zeitschrift fur Rheumatologie"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004800.pub3-BIB0015|cit15","first-page":"69","article-title":"Sulphasalazine in ankylosing spondylitis: a prospective, randomized, double-blind, placebo-controlled study and meta-analysis of other controlled studies","volume":"59","author":"Schmidt","year":"2009","journal-title":"Zeitschrift fur Rheumatologie"},{"issue":"1","key":"10.1002\/14651858.CD004800.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02208032","article-title":"Sulphasalazine in ankylosing spondylitis. A radiological, clinical and laboratory assessment","volume":"10","author":"Taylor","year":"1991","journal-title":"Clinical Rheumatology"},{"issue":"Suppl","key":"10.1002\/14651858.CD004800.pub3-BIB0017|cit17","first-page":"29","article-title":"Sulphasalazine treatment in ankylosing spondylitis: A comparison of sulphasalazine with placebo","volume":"30","author":"Winkler","year":"1989","journal-title":"Magyar Reumatologia"},{"issue":"3A","key":"10.1002\/14651858.CD004800.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/eye.2000.84","article-title":"Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis","volume":"14","author":"Benitez-Del-Castillo","year":"2000","journal-title":"Eye"},{"issue":"9","key":"10.1002\/14651858.CD004800.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1147-53","DOI":"10.1136\/ard.2006.052878","article-title":"Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial","volume":"65","author":"Braun","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD004800.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3899\/jrheum.110885","article-title":"Clinical efficacy of etanercept versus sulfasalazine in ankylosing spondylitis subjects with peripheral joint involvement","volume":"39","author":"Braun","year":"2012","journal-title":"Journal of Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD004800.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/art.30223","article-title":"Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: A randomized, double-blind trial","volume":"63","author":"Braun","year":"2011","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD004800.pub3-BIB0022|cit22","first-page":"A55","article-title":"Assessment of clinical efficacy in a randomized, double-blind study of etanercept and sulphasalazine in patients with ankylosing spondylitis","volume":"39","author":"Freundlich","year":"2009","journal-title":"Internal Medicine Journal"},{"key":"10.1002\/14651858.CD004800.pub3-BIB0023|cit23","first-page":"S73","article-title":"Etanercept is significantly more effective than sulfasalazine in patients with ankylosing spondylitis","volume":"16","author":"Guzman","year":"2010","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1002\/14651858.CD004800.pub3-BIB0024|cit24","unstructured":"NCT00247962 Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis clinicaltrials.gov\/ct2\/show\/record\/NCT00247962 2008"},{"key":"10.1002\/14651858.CD004800.pub3-BIB0025|cit25","first-page":"i55","article-title":"The ankylosing spondylitis disease activity score in subjects treated with etanercept (ETN) or sulfasalazine: Comparison with standard efficacy measures","volume":"49","author":"Heijde","year":"2010","journal-title":"Rheumatology"},{"key":"10.1002\/14651858.CD004800.pub3-BIB0026|cit26","first-page":"1927","article-title":"Clinical improvement with Etanercept versus sulfasalazine treatment in patients with ankylosing spondylitis: Comparative performance of various efficacy measurements (ASCEND)","volume":"62","author":"Heijde","year":"2010","journal-title":"Arthritis and rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD004800.pub3-BIB0027|cit27","first-page":"727","article-title":"A short-term follow-up of enthesitis and arthritis in the active phase of juvenile onset spondyloarthropathies","volume":"20","author":"Burgos-Vargas","year":"2002","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"10","key":"10.1002\/14651858.CD004800.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/ard.61.10.941","article-title":"A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies","volume":"61","author":"Burgos-Vargas","year":"2002","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD004800.pub3-BIB0029|cit29","first-page":"1776","article-title":"Thalidomide delays the rate of relapse in ankylosing spondylitis after discontinuing etanercept treatment","volume":"60","author":"Deng","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD004800.pub3-BIB0030|cit30","unstructured":"NCT00953979 Efficacy and safety of Kunxian capsule in treatment of patients with early ankylosing spondylitis clinicaltrials.gov\/ct2\/show\/record\/NCT00953979"},{"issue":"7","key":"10.1002\/14651858.CD004800.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/annrheumdis-2011-201010","article-title":"Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial","volume":"71","author":"Song","year":"2012","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD004800.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/ard.2010.139667","article-title":"Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): A 48-week randomised controlled trial","volume":"70","author":"Song","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"12","key":"10.1002\/14651858.CD004800.pub3-BIB0033|cit33","first-page":"1093","article-title":"Effects of bushen tongdu decoction on serum tumour necrosis factor-alpha and transforming growth factor beta1, in patients with ankylosing spondylitis","volume":"28","author":"Xu","year":"2008","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi\/Chinese Journal of Integrated Traditional and Western Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004800.pub3-BIB0034|cit34","first-page":"430","article-title":"Clinical study on long-term effectiveness of leflunomide compared with sulfasalazine in treatment of ankylosing spondylitis","volume":"6","author":"Zhao","year":"2006","journal-title":"Pharmaceutical Care and Research"},{"issue":"12","key":"10.1002\/14651858.CD004800.pub3-BIB0035|cit35","first-page":"1506","article-title":"Efficacy of etanercept on ankylosing spondylitis","volume":"29","author":"Zhao","year":"2009","journal-title":"Journal of Shanghai Jiaotong University (Medical Science)"},{"issue":"12","key":"10.1002\/14651858.CD004800.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1002\/art.21492","article-title":"Overestimation of the prevalence of ankylosing spondylitis in the Berlin study: comment on the article by Braun et al","volume":"52","author":"Akkoc","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"9313","key":"10.1002\/14651858.CD004800.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicenter trial","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD004800.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"70","author":"Braun","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004800.pub3-BIB0039|cit39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004524.pub4","article-title":"Methotrexate for ankylosing spondylitis","author":"Chen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD004800.pub3-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002822.pub3","article-title":"Physiotherapy interventions for ankylosing spondylitis","author":"Dagfinrud","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004800.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/art.21330","article-title":"Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy","volume":"53","author":"Davis","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"2","key":"10.1002\/14651858.CD004800.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","article-title":"Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis","volume":"23","author":"Feldtkeller","year":"2003","journal-title":"Rheumatology International"},{"issue":"11","key":"10.1002\/14651858.CD004800.pub3-BIB0043|cit43","first-page":"1482","article-title":"Meta-analysis of sulfasalazine in ankylosing spondylitis","volume":"17","author":"Ferraz","year":"1990","journal-title":"The Journal of Rheumatology"},{"issue":"18","key":"10.1002\/14651858.CD004800.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa012664","article-title":"Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha","volume":"346","author":"Gorman","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004800.pub3-BIB0045|cit45","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD004800.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/berh.2002.0263","article-title":"Seronegative spondyloarthritides","volume":"16","author":"Olivieri","year":"2002","journal-title":"Best Practice and Research Clinical Rheumatology"},{"key":"10.1002\/14651858.CD004800.pub3-BIB0047|cit47","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD004800.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/XXXIV.suppl_2.7","article-title":"Sulphasalazine:\u00a0mechanism of action\u00a0in\u00a0rheumatoid arthritis","volume":"34 Suppl 2","author":"Smedeg\u00e5rd","year":"1995","journal-title":"British Journal of Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD004800.pub3-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000958","article-title":"Sulfasalazine for treating rheumatoid arthritis","author":"Suarez-Almazor","year":"1998","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004800.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/art.511","article-title":"Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy","volume":"46","author":"Bosch","year":"2002","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"10.1002\/14651858.CD004800.pub3-BIB0051|cit51","first-page":"945","article-title":"Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV","volume":"26","author":"Heijde","year":"1999","journal-title":"The Journal of Rheumatology"},{"key":"10.1002\/14651858.CD004800.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"iii24","DOI":"10.1136\/ard.61.suppl_3.iii24","article-title":"Treatment trials in ankylosing spondylitis: current and future considerations","volume":"61 Suppl 3","author":"Heijde","year":"2002","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004800.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.20790","article-title":"Assessment in Ankylosing Spondylitis International Working Group\/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis","volume":"52","author":"Heijde","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"6","key":"10.1002\/14651858.CD004800.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2011.151563","article-title":"2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis","volume":"70","author":"Heijde","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD004800.pub3-BIB0055|cit55","first-page":"613","article-title":"Disability and handicapin in rheumatoid arthritis and ankylosing spondylitis - results from the German rheumatological database.\u00a0German Collaborative Arthritis Centers","volume":"27","author":"Zink","year":"2007","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD004800.pub3-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005468","article-title":"TNF-alpha inhibitors for ankylosing spondylitis","author":"Zochling","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD004800.pub3-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004800.pub2","article-title":"Sulfasalazine for ankylosing spondylitis","author":"Chen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004800.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T17:45:47Z","timestamp":1718646347000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004800.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Musculoskeletal Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,27]]},"references-count":57,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004800.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,27]]}}}